Cardio Diagnostics Holdings, Inc. (CDIO)
1.87
+0.01
(+0.54%)
USD |
NASDAQ |
Oct 09, 16:00
1.86
-0.01
(-0.53%)
After-Hours: 20:00
Cardio Diagnostics Holdings Cash from Operations (Quarterly) : -1.342M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.342M |
| March 31, 2026 | -1.562M |
| December 31, 2025 | -1.362M |
| September 30, 2025 | -1.393M |
| June 30, 2025 | -1.572M |
| March 31, 2025 | -1.400M |
| December 31, 2024 | -1.392M |
| September 30, 2024 | -1.157M |
| June 30, 2024 | -1.210M |
| March 31, 2024 | -1.233M |
| Date | Value |
|---|---|
| December 31, 2023 | -1.686M |
| September 30, 2023 | -1.045M |
| June 30, 2023 | -1.293M |
| March 31, 2023 | -1.649M |
| December 31, 2022 | -3.120M |
| September 30, 2022 | -1.390M |
| June 30, 2022 | -0.3948M |
| March 31, 2022 | -0.1861M |
| December 31, 2021 | -0.5851M |
| September 30, 2021 | 0.0356M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -14.15M |
| Exicure, Inc. | -0.887M |
| Century Therapeutics, Inc. | -19.83M |
| Absci Corp. | -27.56M |
| Celularity, Inc. | 1.447M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0468M |
| Cash from Financing (Quarterly) | -0.1012M |
| Free Cash Flow | -6.106M |
| Free Cash Flow Per Share (Quarterly) | -0.4694 |
| Free Cash Flow to Equity (Quarterly) | -1.226M |
| Free Cash Flow to Firm (Quarterly) | -1.386M |
| Free Cash Flow Yield | -139.2% |